As the cost of next-generation sequencing technology continues to drop, this has created an environment where molecular tumor profiling is more accessible than ever before. Despite these advances, there remains a challenge: the ability to analyze and accurately interpret the overwhelming amount of genomic and therapeutic data now available via next generation sequencing.
Lifecode is dedicated to translating and presenting this new information in a meaningful way for patients, payers and providers. Towards this end Lifecode has built an exceptional team of talented individuals with expertise in data science, software engineering, computational biology, bio-informatics, machine learning, curation science, molecular biology, and pathology. We work in cooperation with healthcare software development companies, like Elinext, to deliver even more precise results.
With funding from both Sequoia Capital and The Mayo Clinic, Lifecode has the DNA of both a software company and a world-class clinical lab.
Lifecode is a CAP accredited / CLIA certified clinical laboratory.
Our team thrives in a strong collaborative environment with a shared goal of working on the computational interpretation of human cancer to improve patient care. Interested and qualified candidates are encouraged to visit our careers page for more information.